SenzaGen Investor Relations Material
Latest events
Q1 2025
SenzaGen
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SenzaGen
Access all reports
SenzaGen is a Sweden-based biotechnology company specializing in non-animal test methods for assessing chemical safety. The company develops and markets in vitro assays for detecting skin sensitization and other toxicological endpoints. Its technology is used in industries including cosmetics, chemicals, and pharmaceuticals. SenzaGen is headquartered in Lund, Sweden, and its shares are listed on the NASDAQ First North Growth Market.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
SENZA
Country
🇸🇪 Sweden